FDA Outlines GMPs for Drugmakers Dealing With COVID-19 Infections in Workers By Sam | June 21, 2020 The FDA on Friday released guidance for drugmakers on good manufacturing practices (GMPs) for responding to COVID-19 infection in employees. Source: Drug Industry Daily Posted in Drug Industry Daily